Company intelligence / Profile preview

Enable Injections

Cincinnati, Ohio, United Statesenableinjections.com ↗
Ownership
Private
Employees
~198
Development stage
Other
01

Overview

Enable Injections has developed the enFuse platform—a purely mechanical, hands-free wearable device that delivers large volumes of drugs subcutaneously. The company’s technology enables patients to self-administer medications at home instead of receiving intravenous infusions at clinics. The first commercial product using enFuse was approved by the FDA in combination with a partner’s therapy. Recent milestones include CE Mark approval in Europe and positive Phase III results for Sarclisa delivered via enFuse. The company has expanded partnerships with major pharma companies such as Roche to develop further combination products.

Therapeutic areas
HematologyOncologyOther
Modalities
Biologics (large molecules)Small moleculesCombination products (drug-device)
Industry
Therapeutic Medical Devices
02

Partnerships

Roche (exclusive worldwide license on certain combinations)Sanofi/partners developing Sarclisa SC formulation using enFuseAdditional undisclosed pharmaceutical partners conducting clinical trials/commercial planning with their therapies combined with enFuse technology.

Beyond the preview

Go deeper on Enable Injections.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enable Injections.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call